Kappos L - Search Results

1

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial.

Wolinsky JS, Arnold DL, Brochet B, Hartung HP, Montalban X, Naismith RT, Manfrini M, Overell J, Koendgen H, Sauter A, Bennett I, Hubeaux S, Kappos L, Hauser SL. Wolinsky JS, et al. Among authors: kappos l. Lancet Neurol. 2020 Dec;19(12):998-1009. doi: 10.1016/S1474-4422(20)30342-2. Epub 2020 Oct 29. Lancet Neurol. 2020. PMID: 33129442 Clinical Trial.

2

[15+/-deoxyspergualin, hope for patients with multiple sclerosis?].

Kappos L, Theobald K, Hartung HP. Kappos L, et al. Nervenarzt. 1992 Dec;63(12):768-71; discussion 772. Nervenarzt. 1992. PMID: 1494394 Review. German. No abstract available.

3

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Miller DH, et al. Among authors: kappos l. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):683-8. doi: 10.1136/jnnp.54.8.683. J Neurol Neurosurg Psychiatry. 1991. PMID: 1940938 Free PMC article.

4

MRI study of Baló's concentric sclerosis before and after immunosuppressive therapy.

Spiegel M, Krüger H, Hofmann E, Kappos L. Spiegel M, et al. Among authors: kappos l. J Neurol. 1989 Dec;236(8):487-8. doi: 10.1007/BF00328514. J Neurol. 1989. PMID: 2614497

5

Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.

Kappos L, Patzold U, Dommasch D, Poser S, Haas J, Krauseneck P, Malin JP, Fierz W, Graffenried BU, Gugerli US. Kappos L, et al. Ann Neurol. 1988 Jan;23(1):56-63. doi: 10.1002/ana.410230110. Ann Neurol. 1988. PMID: 3278672 Clinical Trial.

6

Treatment of multiple sclerosis with 15 +/- deoxyspergualin. Design of a controlled study with close MRI-monitoring.

Kappos L, Radü EW, Bernasconi L, Brunnschweiler H, Hartung HP, Haas J, Gehlen W, Hartard C, Lagreze HL, Rüttinger H, et al. Kappos L, et al. Schweiz Arch Neurol Psychiatr (1985). 1993;144(3):198-201. Schweiz Arch Neurol Psychiatr (1985). 1993. PMID: 7687364 Clinical Trial.

7

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study.

Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Filippi M, et al. Among authors: kappos l. Neurology. 1995 Feb;45(2):255-60. doi: 10.1212/wnl.45.2.255. Neurology. 1995. PMID: 7854522 Clinical Trial.

8

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L. Leppert D, et al. Among authors: kappos l. Brain. 1998 Dec;121 ( Pt 12):2327-34. doi: 10.1093/brain/121.12.2327. Brain. 1998. PMID: 9874483

9

[Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis].

Zimmermann C, Walther EU, Goebels N, Lienert C, Kappos L, Hartung HP, Hohlfeld R. Zimmermann C, et al. Among authors: kappos l. Nervenarzt. 1999 Aug;70(8):759-63. doi: 10.1007/s001150050508. Nervenarzt. 1999. PMID: 10483579 Clinical Trial. German.

10

The contribution of magnetic resonance imaging in the differential diagnosis of the damage of the cerebral hemispheres.

Grossman RI, Kappos L, Wolinsky JS. Grossman RI, et al. Among authors: kappos l. J Neurol Sci. 2000 Jan 15;172 Suppl 1:S57-62. doi: 10.1016/s0022-510x(99)00281-6. J Neurol Sci. 2000. PMID: 10606809 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

791 results

Search Page